You are requesting information on: CAR-T For Relapsed/Refractory AML: From Discovery To First-In-Human Active Phase 1 Evaluation Miltenyi Bioindustry
Already a member of Cell & Gene or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below: